SC US (TTGP), LTD.SC US (TTGP), LTD.

Institutional investor · Portfolio as of Q2 2019

SEC EDGAR SourceSEC Filings

Top Holdings8 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

Guardant Health, Inc.

7.8M$672M45.9%$76.70+12.56%
2 qtrssince 2019-Q1
Unchanged
0

UBER TECHNOLOGIES INC

6.2M$288.6M19.7%$46.380.00%
1 qtr
New
98

SNAP INC - A

8M$113.8M7.8%$11.02+29.76%
2 qtrssince 2019-Q1
Unchanged
0
PDDPDD
ADR

PDD HOLDINGS INC

5.3M$108.6M7.4%$24.80-16.81%
2 qtrssince 2019-Q1
Unchanged
0

BLOCK INC

1.3M$97.5M6.7%$74.92-3.19%
2 qtrssince 2019-Q1
Unchanged
0

SUNRUN INC

3.7M$70.1M4.8%$14.06-27.52%
2 qtrssince 2019-Q1
Decreased
0

BRIDGEBIO PHARMA INC

2.5M$68.6M4.7%$26.970.00%
1 qtr
New
85

QUINCE THERAPEUTICS INC

1M$44.2M3.0%$42.510.00%
1 qtr
New
84
$1.5B
AUM
8
Positions
Q2 2019
Filing
Rating · 2.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q2'19
New91%Increased0%Decreased8%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q38%1-4Q63%1-2Y0%2Y+0%

SC US (TTGP), LTD. manages $1.5B across 8 positions as of Q2 2019. Top holdings: GH (45.9%), UBER (19.7%), SNAP (7.8%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.

Q2 2019 Summary

Added 3 new positions, exited 2, trimmed 1. Top move: UBER (NEW, conviction 98). Portfolio: $1.5B across 8 positions.

Top holdings by portfolio weight

Total AUM$1B
GH45.92%
UBER19.72%
SNAP7.78%
PDD7.42%
XYZ6.66%
RUN4.79%
BBIO4.69%
QNCX3.02%
DBX0.00%
GOOG0.00%

Portfolio allocation by GICS sector

Sectors4
Healthcare53.63%
Technology31.17%
Communication Services7.78%
Consumer Cyclical7.42%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction39
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
FIGFIGFIGMA INC-CL A
Q1 2026 Q2 2026+1.5M shares-$460.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used